Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 0517-0901, Hydralazine Hydrochloride, injection, solution, from American Regent, Inc..

Product NDC
0517-0901
Status
Listed
Labeler
American Regent, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040136
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0517-0901 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
0517-0901-250051709012525 VIAL, SINGLE-DOSE in 1 TRAY (0517-0901-25) / 1 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/17210abc-58f6-442e-8ff2-7971333c82f6
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0517-0901

Use it

Look up 0517-0901 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0517-0901 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0517-0901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.